NBSE

8-K - NeuBase Therapeutics, Inc. (0001173281) (Filer)

DEFA14A - NeuBase Therapeutics, Inc. (0001173281) (Filer)

8-K - NeuBase Therapeutics, Inc. (0001173281) (Filer)

Gainers Monogram Orthopaedics (NASDAQ:MGRM) stock increased by 19.1% to $2.31 during Monday's pre-market session. The company's market cap stands at $73.1 million. Allarity Therapeutics (NASDAQ:ALLR) shares moved upwards by 13.99% to $1.14. The market value of their outstanding shares is at $2.2 million. VYNE Therapeutics (NASDAQ:VYNE) shares increased by 13.74% to $2.98. The company's market cap stands at $42.0 million. Allogene Therapeutics (NASDAQ:ALLO) stock increased by 13.02% to $3.47. The market value of their outstanding shares is at $592.4 million. Sunshine Biopharma (NASDAQ:SBFM) stock rose 12.55% to $0.95. Addex Therapeutics (NASDAQ:ADXN) shares increased by 12.4% to $10.06.

DEFA14A - NeuBase Therapeutics, Inc. (0001173281) (Filer)

Gainers NeuBase Therapeutics (NASDAQ:NBSE) stock increased by 11.1% to $0.45 during Friday's after-market session. The market value of their outstanding shares is at $1.6 million. Aptevo Therapeutics (NASDAQ:APVO) shares moved upwards by 7.17% to $1.06. The company's market cap stands at $3.8 million. Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 6.72% to $0.2. The market value of their outstanding shares is at $10.7 million. Alzamend Neuro (NASDAQ:ALZN) shares rose 5.85% to $0.77. The company's market cap stands at $5.2 million. Asensus Surgical (AMEX:ASXC) shares increased by 5.43% to $0.25. The company's market cap stands at $69.1 million. cbdMD (AMEX:YCBD) stock rose 5.

- SEC Filing

- SEC Filing

8-K - NeuBase Therapeutics, Inc. (0001173281) (Filer)

Gainers Qilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 50.4% to $1.14 during Friday's after-market session. The company's market cap stands at $40.7 million. Allarity Therapeutics (NASDAQ:ALLR) stock rose 18.09% to $2.48. The market value of their outstanding shares is at $1.1 million. Galecto (NASDAQ:GLTO) stock increased by 5.58% to $0.72. The company's market cap stands at $19.4 million. Finch Therapeutics Gr (NASDAQ:FNCH) shares increased by 5.28% to $2.19. The company's market cap stands at $3.5 million. CNS Pharma (NASDAQ:CNSP) stock rose 4.97% to $0.26. The market value of their outstanding shares is at $2.7 million. Cormedix (NASDAQ:CRMD) shares rose 4.96% to $6.13. Th

DEF 14A - NeuBase Therapeutics, Inc. (0001173281) (Filer)

8-K - NeuBase Therapeutics, Inc. (0001173281) (Filer)

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the "Rule") as a result of its failure to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "Form 10-K") in a timely manner. This Notice has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market. Under Nasdaq rules, the Company has 60 calendar days from receipt o

PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the "Rule") as a result of its failure to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "Form 10-K") in a timely manner. This Notice has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market. Under Nasdaq rule

Neubase Therapeutics Inc (NASDAQ:NBSE) shares are trading lower by 53% to $0.47 during Tuesday’s session after the company on Monday announced it is holding a Special Meeting of Stockholders on May 13, online, to discuss and vote on the proposed liquidation and dissolution of the company, along with an adjournment proposal if necessary. The Board of Directors unanimously recommends voting in favor of these proposals, considering them beneficial for NeuBase and its stockholders. The meeting will be conducted virtually, and stockholders must register by May 12, to attend. It’s emphasized that both attending and voting are important, and detailed instructions on how to participate and vot

Shares of Westport Fuel Systems Inc. (NASDAQ:WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Stoke Therapeutics, Inc. (NASDAQ:STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. C3is Inc. (NASDAQ:CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-q

Gainers Stoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out yesterday. Mesoblast (NASDAQ:MESO) stock moved upwards by 64.95% to $3.63. The market value of their outstanding shares is at $368.2 million. OpGen (NASDAQ:OPGN) shares increased by 42.1% to $0.68. The company's market cap stands at $6.7 million. Alpha Teknova (NASDAQ:TKNO) shares rose 36.92% to $3.3. The market value of their outstanding shares is at $134.6 million. Nuvation Bio (NYSE:NUVB) shares moved upwards by 32.22% to $2.98. The company's market cap stands at $651.6 million. Journe

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% to 16,448.92. The S&P 500 also fell, dropping, 0.23% to 5,230.19. Check This Out: Top 3 Energy Stocks That May Keep You Up At Night In Q1   Leading and Lagging Sectors   Consumer discretionary shares jumped by 0.7% on Monday. In trading on Monday, energy shares fell by 0.2%.   Top Headline   U.S. durable goods orders increased by 1.4% month-over-month in February versus a revised 6.9% decline in January.   Equities Trading UP   Stoke Therapeutics, Inc. (NASDAQ:STOK) shares shot up 74% to $11.31 after the company

Gainers Stoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $522.8 million. As per the press release, Q4 earnings came out yesterday. OpGen (NASDAQ:OPGN) shares moved upwards by 77.6% to $0.84. The market value of their outstanding shares is at $8.4 million. ABVC BioPharma (NASDAQ:ABVC) stock increased by 45.71% to $1.53. The market value of their outstanding shares is at $16.1 million. Mesoblast (NASDAQ:MESO) shares moved upwards by 32.27% to $2.91. The market value of their outstanding shares is at $295.3 million. Praxis Precision Medicine (NASDAQ:PRAX) shares increased by 21.38% to

Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Check-Cap Ltd. (NASDAQ:CHEK) shares gained 38.3% to $2.67 in pre-market trading. Nobul AI Corp entered into business combination agreement with Check-Cap. C3is Inc. (NASDAQ:CISS) rose 35.2% to $0.0476 in pre-market trading. C3is is expected to release its fourth quarter financial results before the opening bell on March 26, 2024. OpGen, Inc. (NASDAQ:OPGN) ga

Gainers Stoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market cap stands at $515.7 million. As per the news, the Q4 earnings report came out today. OpGen (NASDAQ:OPGN) shares moved upwards by 66.61% to $0.79. The market value of their outstanding shares is at $7.9 million. Universe Pharmaceuticals (NASDAQ:UPC) stock rose 11.62% to $1.92. The company's market cap stands at $7.0 million. Vaxxinity (NASDAQ:VAXX) shares moved upwards by 7.99% to $0.72. The company's market cap stands at $90.8 million. Unity Biotechnology (NASDAQ:UBX) stock rose 7.39% to $1.7. The market value of their outstanding shares is at $28.4 mi

PRE 14A - NeuBase Therapeutics, Inc. (0001173281) (Filer)

8-K - NeuBase Therapeutics, Inc. (0001173281) (Filer)

Shares of Freshpet, Inc. (NASDAQ:FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. Freshpet posted quarterly earnings of 31 cents per share, beating market estimates of 5 cents per share. The company’s quarterly sales came in at $215.42 million versus expectations of $204.36 million. Freshpet shares gained 15.5% to $106.29 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Akili, Inc. (NASDAQ:AKLI) shares jumped 126% to $0.5009 after the company reported positive results from Shionogi's Phase 3 clinical trial of localized version of Akili's EndeavorRx® for Pediatric ADHD patients in Japan. Z

Shares of Intuitive Machines, Inc. (NASDAQ:LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown near the moon’s south pole. Intuitive Machines shares dipped 30.1% to $6.71 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) gained 66% to $1.33 in pre-market trading after surging over 30% on Friday. Semilux International Ltd. (NASDAQ:SELX) shares rose 43.9% to $1.64 in pre-market trading after dipping 21% on Friday. Rubicon Technologies, Inc. (NYSE:RBT) shares gained 14.8% to $0.9699 in pre-market tradi